Host factors in the alphavirus replication complex
甲病毒复制复合物中的宿主因子
基本信息
- 批准号:7185849
- 负责人:
- 金额:$ 32.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-02-01 至 2010-01-31
- 项目状态:已结题
- 来源:
- 关键词:AlphavirusAntibodiesAntibody AffinityArthritisBindingBinding ProteinsBiochemicalBiological AssayBioterrorismCategoriesCellsCenters for Disease Control and Prevention (U.S.)Cessation of lifeComplexCytolysisCytoplasmDevelopmentDiseaseEncephalitisEncephalitis VirusesEndoribonucleasesEnvironmentEquus caballusExanthemaFamilyFamily memberFeverFluorescence MicroscopyFutureGenomeGenomicsGoalsGreen Fluorescent ProteinsHumanImmunologic TechniquesInfectionIntegration Host FactorsInterventionMammalsMapsMembraneModelingMolecularMolecular GeneticsNational Institute of Allergy and Infectious DiseasePolyproteinsProcessProductionProtein OverexpressionProteinsProteolytic ProcessingProteomicsRNARNA InterferenceRNA VirusesRNA chemical synthesisRNA-Protein InteractionRas Signaling PathwayRepliconResearchRoleRoss river virusSH3 DomainsSindbis VirusSwitching ComplexTechniquesTestingTherapeutic AgentsTogaviridaeVenezuelan Equine EncephalomyelitisViralViral Nonstructural ProteinsViral Structural ProteinsVirusVirus Replicationdomain mappingendoribonucleasegenome sequencinginhibitor/antagonistknock-downmagnetic beadsmembermutantpathogenras GTPase-Activating Proteinsreplicaseresearch studytherapeutic targetviral RNA
项目摘要
DESCRIPTION (provided by applicant): Infection of humans and other mammals by members of the Alphavirus genus within the Togaviridae can result in fever, rash, arthritis, encephalitis and death. Several alphaviruses have been designated by the Centers for Disease Control and Prevention as Category B agents of concern for possible use in bioterrorism, and as Priority Pathogens by the NIAID. There is currently no specific treatment available for diseases caused by these pathogens.
We are studying Alphavirus replication with the long-term goal of identifying potential therapeutic targets. Replication of incoming positive-sense genomic RNA, which occurs in membrane-associated complexes containing the viral nonstructural proteins (nsPs), first generates a minus strand copy, followed by new progeny plus strand RNAs. We hypothesize that in addition to known differences in the viral nsP components of the minus and plus strand replicases, that recruitment of different host factors facilitates their disparate functions. We also hypothesize that alphaviruses utilize a common strategy of host factor recruitment to replicate their respective genomes.
Using mutants expressing a tagged nsP3 protein, we propose to use immunological techniques to isolate the plus and minus strand replicases from three representative alphaviruses, Sindbis virus, Ross River virus, and Venezuelan equine encephalitis virus. The host factors present in the replication complexes will be identified by proteomic techniques. Focusing on factors commonly present in the Alphavirus plus and/or minus strand replicase complexes, we will verify each factor's association with the replicase in intact cells using confocal fluorescence microscopy. Using molecular and biochemical approaches, we will assess the effects of associated host components on viral replication and map the protein-protein (or protein-RNA) interactions of the host factors. Understanding the components of and molecular interactions within the Alphavirus minus and plus strand replicases will facilitate future exploration for inhibitors of these important pathogens.
描述(由申请人提供):togaviridae内α病毒属成员对人类和其他哺乳动物的感染可能导致发烧,皮疹,关节炎,脑炎和死亡。疾病控制和预防中心已将几种α病毒指定为B类关注生物恐怖主义的关注者,而NIAID的优先病原体被指定为使用。目前尚无针对这些病原体引起的疾病的特定治疗方法。
我们正在研究α病毒复制,其长期目标是确定潜在的治疗靶标。传入的阳性基因组RNA的复制,发生在包含病毒非结构蛋白(NSP)的膜相关复合物中,首先生成负链拷贝,然后再产生新的后代加上链链RNA。 我们假设,除了负和链复制酶的病毒NSP成分的已知差异外,募集不同宿主因素还有助于其不同的功能。 我们还假设α病毒利用宿主因子募集的共同策略来复制其各自的基因组。
使用表达标记为NSP3蛋白的突变体,我们建议使用免疫学技术将来自三种代表性α的加分和负链复制酶分离出来,Sindbis病毒,Ross River病毒和委内瑞拉人马肺炎病毒。复制络合物中存在的宿主因子将通过蛋白质组学技术识别。 侧重于α病毒Plus和/或减去链复制酶复合物中常见的因素,我们将使用共焦荧光显微镜验证每个因素与完整细胞中复制酶的关联。 使用分子和生化方法,我们将评估相关宿主成分对病毒复制的影响,并绘制宿主因子的蛋白质蛋白质(或蛋白-RNA)相互作用。 了解α病毒减去和加上链复制中的成分和分子相互作用的成分和分子相互作用,将促进对这些重要病原体的抑制剂的未来探索。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARGARET R MACDONALD其他文献
MARGARET R MACDONALD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARGARET R MACDONALD', 18)}}的其他基金
Powassan virus nanobodies from camelid monomeric variable antibody domains elicited by natural infection
自然感染引起的骆驼单体可变抗体域的波瓦桑病毒纳米抗体
- 批准号:
10043364 - 财政年份:2020
- 资助金额:
$ 32.05万 - 项目类别:
Powassan virus nanobodies from camelid monomeric variable antibody domains elicited by natural infection
自然感染引起的骆驼单体可变抗体域的波瓦桑病毒纳米抗体
- 批准号:
10192656 - 财政年份:2020
- 资助金额:
$ 32.05万 - 项目类别:
Genome wide siRNA screen for identifying host factors required for ZAP function
全基因组 siRNA 筛选,用于鉴定 ZAP 功能所需的宿主因子
- 批准号:
8289157 - 财政年份:2012
- 资助金额:
$ 32.05万 - 项目类别:
Upregulation of ZAP expression as a novel approach for anti-alphavirus therapy
ZAP 表达上调作为抗甲病毒治疗的新方法
- 批准号:
8420421 - 财政年份:2012
- 资助金额:
$ 32.05万 - 项目类别:
Upregulation of ZAP expression as a novel approach for anti-alphavirus therapy
ZAP 表达上调作为抗甲病毒治疗的新方法
- 批准号:
8298821 - 财政年份:2012
- 资助金额:
$ 32.05万 - 项目类别:
Genome wide siRNA screen for identifying host factors required for ZAP function
全基因组 siRNA 筛选,用于鉴定 ZAP 功能所需的宿主因子
- 批准号:
8434103 - 财政年份:2012
- 资助金额:
$ 32.05万 - 项目类别:
Host factor DNAJC14 as a novel target for broad spectrum anti-flavivirus activity
宿主因子 DNAJC14 作为广谱抗黄病毒活性的新靶标
- 批准号:
8132747 - 财政年份:2010
- 资助金额:
$ 32.05万 - 项目类别:
Development of a genetically tractable nematode model of alphavirus infection
甲病毒感染的遗传易驯化线虫模型的开发
- 批准号:
7661284 - 财政年份:2009
- 资助金额:
$ 32.05万 - 项目类别:
Development of a genetically tractable nematode model of alphavirus infection
甲病毒感染的遗传易驯化线虫模型的开发
- 批准号:
7764768 - 财政年份:2009
- 资助金额:
$ 32.05万 - 项目类别:
Host factors in the alphavirus replication complex
甲病毒复制复合物中的宿主因子
- 批准号:
7006656 - 财政年份:2005
- 资助金额:
$ 32.05万 - 项目类别:
相似国自然基金
基于计算生物学技术小分子农兽药残留物驼源单域抗体虚拟筛选与亲和力成熟 -以内蒙古阿拉善双峰驼为例
- 批准号:32360190
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
框架核酸多价人工抗体增强靶细胞亲和力用于耐药性肿瘤治疗
- 批准号:32301185
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
中国年轻女性接种不同剂次国产双价HPV16/18疫苗的特异性抗体亲和力及细胞免疫反应研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
中国年轻女性接种不同剂次国产双价HPV16/18疫苗的特异性抗体亲和力及细胞免疫反应研究
- 批准号:82273723
- 批准年份:2022
- 资助金额:52.00 万元
- 项目类别:面上项目
基于酵母展示与自体持续突变的纳米抗体快速亲和力成熟技术研究
- 批准号:82204046
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
B Cell Epitope Discovery and Mechanisms of Antibody Protection: Responses to Dengue 4, Powassan, Chikungunya, and Venezuelan Equine Encephalitis Viruses
B 细胞表位发现和抗体保护机制:对登革热 4、Powassan、基孔肯雅热和委内瑞拉马脑炎病毒的反应
- 批准号:
10909763 - 财政年份:2023
- 资助金额:
$ 32.05万 - 项目类别:
Human Monoclonal Antibodies for Encephalitic Alphaviruses
脑炎甲病毒的人单克隆抗体
- 批准号:
10539155 - 财政年份:2022
- 资助金额:
$ 32.05万 - 项目类别:
Multiplexed imaging of viral protein processing and assembly in live cells
活细胞中病毒蛋白加工和组装的多重成像
- 批准号:
10708987 - 财政年份:2022
- 资助金额:
$ 32.05万 - 项目类别:
B Cell Epitope Discovery and Mechanisms of Antibody Protection: Responses to Dengue 4, Powassan, Chikungunya, and Venezuelan Equine Encephalitis Viruses
B 细胞表位发现和抗体保护机制:对登革热 4、Powassan、基孔肯雅热和委内瑞拉马脑炎病毒的反应
- 批准号:
10662175 - 财政年份:2022
- 资助金额:
$ 32.05万 - 项目类别:
Multiplexed imaging of viral protein processing and assembly in live cells
活细胞中病毒蛋白加工和组装的多重成像
- 批准号:
10587280 - 财政年份:2022
- 资助金额:
$ 32.05万 - 项目类别: